1. Home
  2. ICU vs PRPO Comparison

ICU vs PRPO Comparison

Compare ICU & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

HOLD

Current Price

$0.32

Market Cap

15.9M

Sector

Health Care

ML Signal

HOLD

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$24.97

Market Cap

32.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ICU
PRPO
Founded
2018
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
15.9M
32.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ICU
PRPO
Price
$0.32
$24.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.3M
14.5K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$881,000.00
$22,800,000.00
Revenue This Year
$691.85
N/A
Revenue Next Year
$64.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1195.59
30.95
52 Week Low
$0.29
$3.90
52 Week High
$3.07
$28.50

Technical Indicators

Market Signals
Indicator
ICU
PRPO
Relative Strength Index (RSI) 35.81 58.24
Support Level $0.32 $23.92
Resistance Level $0.36 $25.62
Average True Range (ATR) 0.03 1.42
MACD 0.01 -0.07
Stochastic Oscillator 31.20 74.25

Price Performance

Historical Comparison
ICU
PRPO

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: